Beyond Air Inc (XAIR)

$0.41 -0.04 (-8.29%)
Market Cap 6.20M
Revenue (ttm) 3.71M
Net Income (ttm) -46.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,256.87%
Debt to Equity Ratio 2.65
Volume 149,100
Avg Vol 330,556
Day's Range N/A - N/A
Shares Out 13.19M
Stochastic %K 16%
Beta 0.26
Analysts Sell
Price Target $2.00

Company Profile

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiol...

Industry: Medical Devices
Sector: Healthcare
Phone: 516 665 8200
Address:
900 Stewart Avenue, Suite 301, Garden City, United States
Say_Whaaaat
Say_Whaaaat Jun. 5 at 9:49 PM
$XAIR if they do a 10 to 1 split, that means pre both splits, for every 1000 shares you had you'll now how 5! Thanks Lisi!
0 · Reply
Fufat
Fufat Jun. 1 at 1:27 PM
$XAIR from $4.20 ish high to .45. This is criminal! Why thr steep drop? This has been shorted to high heaven. The company is still moving forward with their products. Nothing really changed other than the old CEO left. We shouldnt be down here but here we are!
1 · Reply
DingleberryDandy
DingleberryDandy Jun. 1 at 12:33 PM
$XAIR not dead yet. they can remain listed for a while longer. looks like a r/s is coming within a month
0 · Reply
DirtDobber
DirtDobber Jun. 1 at 12:10 PM
$XAIR let’s hope we get some saving action,
0 · Reply
Say_Whaaaat
Say_Whaaaat Jun. 1 at 12:05 PM
$XAIR the news this morning is "Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing"..... Yet the price goes red 😆. Good news bad.
1 · Reply
domarffm
domarffm Jun. 1 at 12:04 PM
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing $XAIR https://www.beyondair.net/news-events/press-releases?i=166822
0 · Reply
ncaro3
ncaro3 May. 26 at 12:07 PM
$XAIR Anybody want to chip in and buy this train wreck of a company? I found 57 cents in my couch cushions?
1 · Reply
iNVidiousGeek
iNVidiousGeek May. 23 at 4:58 PM
$XAIR Ready to catch it's Second breath! !
0 · Reply
uptrend2025
uptrend2025 May. 22 at 2:37 PM
$XAIR This one is super risk reward. It could go to cents or go to over $1 depending on Nasdaq ruling anyday now. I prefer to stay out and watch until decision is made.
1 · Reply
VernCapital
VernCapital May. 20 at 8:35 PM
$XAIR looking good - down to about 2cents now
1 · Reply
Latest News on XAIR
Beyond Air receives Nasdaq hearing panel decision granting continued listing

2026-06-01T13:58:00.000Z - 4 days ago

Beyond Air receives Nasdaq hearing panel decision granting continued listing

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Jun 1, 2026, 8:00 AM EDT - 4 days ago

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing

Beyond Air Proxy statement: Proxy filing

May 5, 2026, 8:00 AM EDT - 4 weeks ago

Beyond Air Proxy statement: Proxy filing

Beyond Air Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 6 weeks ago

Beyond Air Proxy statement: Proxy filing

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

2026-04-20T12:58:40.000Z - 6 weeks ago

Beyond Air’s Beyond Cancer reports updated data from Phase 1 UNO trial

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Apr 20, 2026, 8:00 AM EDT - 6 weeks ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

Apr 15, 2026, 8:00 AM EDT - 7 weeks ago

Beyond Air to Participate in the D. Boral Capital Global Conference 2026

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

2026-03-26T20:10:58.000Z - 2 months ago

Beyond Air CEO Steve Lisi resigns, Robert Goodman succeeds

Beyond Air subsidiary reports signs of clinical activity from UNO trial

2026-03-17T20:45:51.000Z - 2 months ago

Beyond Air subsidiary reports signs of clinical activity from UNO trial

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 17, 2026, 4:35 PM EDT - 2 months ago

Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Beyond Air Transcript: Life Sciences Virtual Investor Forum

Mar 12, 2026, 2:30 PM EDT - 3 months ago

Beyond Air Transcript: Life Sciences Virtual Investor Forum

Beyond Air announces termination of NeuroNOS agreement with XTL

2026-03-10T11:35:43.000Z - 3 months ago

Beyond Air announces termination of NeuroNOS agreement with XTL

XTLB

Beyond Air announces publication of review article on effects of iNO

2026-02-20T13:08:00.000Z - 3 months ago

Beyond Air announces publication of review article on effects of iNO

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

Feb 20, 2026, 8:00 AM EST - 3 months ago

Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections

Beyond Air price target lowered to $2 from $6 at JonesResearch

2026-02-19T21:31:02.000Z - 3 months ago

Beyond Air price target lowered to $2 from $6 at JonesResearch

Beyond Air Earnings Call Transcript: Q3 2026

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Earnings Call Transcript: Q3 2026

Beyond Air Earnings release: Q3 2026

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Earnings release: Q3 2026

Beyond Air Quarterly report: Q3 2026

Feb 13, 2026, 8:00 AM EST - 4 months ago

Beyond Air Quarterly report: Q3 2026

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

2026-02-13T12:36:07.000Z - 4 months ago

Beyond Air reports Q3 EPS (85c) vs ($2.96) last year

Beyond Air sees FY26 revenue $8M-$10M, consensus $8.28M

2026-02-13T12:36:01.000Z - 4 months ago

Beyond Air sees FY26 revenue $8M-$10M, consensus $8.28M

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Feb 13, 2026, 7:30 AM EST - 4 months ago

Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Beyond Air Slides: Corporate presentation

Feb 13, 2026, 6:00 AM EST - 4 months ago

Beyond Air Slides: Corporate presentation

Beyond Air files to sell 7.86M shares of common stock for holders

2026-01-30T21:10:38.000Z - 4 months ago

Beyond Air files to sell 7.86M shares of common stock for holders

Beyond Air Registration statement: Registration Filing

Jan 30, 2026, 7:00 AM EST - 4 months ago

Beyond Air Registration statement: Registration Filing

XTL Biopharmaceuticals provides update on recent developments

2026-01-29T21:40:19.000Z - 4 months ago

XTL Biopharmaceuticals provides update on recent developments

XTLB

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Jan 27, 2026, 4:05 PM EST - 4 months ago

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Beyond Air initiated with a Buy at Rodman & Renshaw

2026-01-20T12:35:20.000Z - 4 months ago

Beyond Air initiated with a Buy at Rodman & Renshaw

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Jan 15, 2026, 1:30 PM EST - 5 months ago

Beyond Air Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Beyond Air prices 3.93M shares at $1.272 in private placement

2026-01-14T13:45:25.000Z - 5 months ago

Beyond Air prices 3.93M shares at $1.272 in private placement

Why Is Beyond Air Stock (XAIR) Up Today?

2026-01-13T13:23:31.000Z - 5 months ago

Why Is Beyond Air Stock (XAIR) Up Today?

XTLB

XTL Biopharmaceuticals to acquire 85% of Beyond Air’s NeuroNOS for $32.5M

2026-01-13T12:35:15.000Z - 5 months ago

XTL Biopharmaceuticals to acquire 85% of Beyond Air’s NeuroNOS for $32.5M

XTLB

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Jan 13, 2026, 7:30 AM EST - 5 months ago

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Beyond Air appoints Dan Moorhead as CFO

2025-12-30T12:45:32.000Z - 5 months ago

Beyond Air appoints Dan Moorhead as CFO

Beyond Air Proxy statement: Proxy Filing

Dec 19, 2025, 7:00 AM EST - 6 months ago

Beyond Air Proxy statement: Proxy Filing

Beyond Air signs new international LungFit PH distribution agreements

2025-12-17T12:35:22.000Z - 6 months ago

Beyond Air signs new international LungFit PH distribution agreements

Beyond Air Registration statement: Registration Filing

Dec 11, 2025, 7:00 AM EST - 6 months ago

Beyond Air Registration statement: Registration Filing

Beyond Air announces resignation of CFO Doug Larson

2025-11-26T21:35:19.000Z - 6 months ago

Beyond Air announces resignation of CFO Doug Larson

Beyond Air® Announces Transition of Chief Financial Officer

Nov 26, 2025, 4:30 PM EST - 6 months ago

Beyond Air® Announces Transition of Chief Financial Officer

Beyond Air Registration statement: Registration Filing

Nov 21, 2025, 7:00 AM EST - 7 months ago

Beyond Air Registration statement: Registration Filing

Beyond Air Earnings Call Transcript: Q2 2026

Nov 10, 2025, 4:30 PM EST - 7 months ago

Beyond Air Earnings Call Transcript: Q2 2026

Beyond Air Quarterly report: Q2 2026

Nov 10, 2025, 4:30 PM EST - 7 months ago

Beyond Air Quarterly report: Q2 2026

Beyond Air Earnings release: Q2 2026

Nov 10, 2025, 4:30 PM EST - 7 months ago

Beyond Air Earnings release: Q2 2026

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Nov 10, 2025, 4:05 PM EST - 7 months ago

Beyond Air® Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update

Beyond Air Slides: Corporate presentation

Nov 10, 2025, 7:00 AM EST - 7 months ago

Beyond Air Slides: Corporate presentation

Beyond Air Registration statement: Registration Filing

Sep 30, 2025, 8:00 AM EDT - 8 months ago

Beyond Air Registration statement: Registration Filing

Beyond Air Registration statement: Registration Filing

Sep 25, 2025, 8:00 AM EDT - 9 months ago

Beyond Air Registration statement: Registration Filing

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Sep 22, 2025, 8:00 AM EDT - 9 months ago

Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Sep 8, 2025, 3:55 PM EDT - 9 months ago

Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 8:00 AM EDT - 9 months ago

Beyond Air to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Aug 20, 2025, 8:00 AM EDT - 10 months ago

Beyond Air Signs New International LungFit PH® Distribution Agreements, Most Notably in Japan

Beyond Air Earnings Call Transcript: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Beyond Air Earnings Call Transcript: Q1 2026

Beyond Air Earnings release: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Beyond Air Earnings release: Q1 2026

Beyond Air Quarterly report: Q1 2026

Aug 12, 2025, 4:30 PM EDT - 10 months ago

Beyond Air Quarterly report: Q1 2026

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Jul 25, 2025, 8:00 AM EDT - 11 months ago

Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Jul 22, 2025, 7:30 AM EDT - 11 months ago

Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.

Beyond Air Earnings Call Transcript: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings Call Transcript: Q4 2025

Beyond Air Annual report: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Annual report: Q4 2025

Beyond Air Earnings release: Q4 2025

Jun 17, 2025, 4:30 PM EDT - 1 year ago

Beyond Air Earnings release: Q4 2025

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Jun 17, 2025, 4:01 PM EDT - 1 year ago

Beyond Air® Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Jun 16, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Submits FDA PMA Supplement for Next Generation LungFit® PH

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

May 20, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast

Beyond Air Proxy statement: Proxy Filing

May 5, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Beyond Air Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

Apr 21, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Apr 15, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Apr 9, 2025, 4:05 PM EDT - 1 year ago

Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients' Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Mar 11, 2025, 7:30 AM EDT - 1 year ago

Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH

Beyond Air Earnings Call Transcript: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q3 2025

Beyond Air Quarterly report: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q3 2025

Beyond Air Earnings release: Q3 2025

Feb 10, 2025, 4:30 PM EST - 1 year ago

Beyond Air Earnings release: Q3 2025

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Feb 10, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Feb 5, 2025, 9:29 AM EST - 1 year ago

Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Beyond Air Registration statement: Registration Filing

Jan 31, 2025, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Jan 27, 2025, 4:05 PM EST - 1 year ago

Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Jan 24, 2025, 9:15 AM EST - 1 year ago

Beyond Air® Announces LungFit® PH Receives Market Authorization in Australia

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

Jan 13, 2025, 10:30 AM EST - 1 year ago

Beyond Air Transcript: Lytham Partners 2025 Investor Healthcare Summit

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Dec 9, 2024, 11:00 AM EST - 1 year ago

National Advertising Division Recommends Beyond Air Discontinue or Modify Comparative Safety Claims for its iNO Products

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 4, 2024, 4:30 PM EST - 1 year ago

Beyond Air Transcript: Piper Sandler 36th Annual Healthcare Conference

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Dec 3, 2024, 4:05 PM EST - 1 year ago

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

Dec 2, 2024, 7:30 AM EST - 1 year ago

Beyond Air Receives CE Mark in Europe for the LungFit® PH System

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Nov 26, 2024, 7:30 AM EST - 1 year ago

NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board

Beyond Air Registration statement: Registration Filing

Nov 21, 2024, 7:00 AM EST - 1 year ago

Beyond Air Registration statement: Registration Filing

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 14, 2024, 4:05 PM EST - 1 year ago

Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference

Beyond Air Earnings Call Transcript: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Earnings Call Transcript: Q2 2025

Beyond Air Quarterly report: Q2 2025

Nov 11, 2024, 4:30 PM EST - 1 year ago

Beyond Air Quarterly report: Q2 2025

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Nov 11, 2024, 4:05 PM EST - 1 year ago

Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update

Beyond Air Proxy statement: Proxy Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Oct 29, 2024, 4:22 PM EDT - 1 year ago

Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast

Beyond Air Registration statement: Registration Filing

Oct 25, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Beyond Air Proxy statement: Proxy Filing

Oct 18, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Proxy statement: Proxy Filing

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 7, 2024, 7:00 AM EDT - 1 year ago

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Oct 2, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Partners with Healthcare Links to Expand Access to LungFit® PH System Through Group Purchasing Organizations and Integrated Delivery Networks

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Sep 27, 2024, 7:34 AM EDT - 1 year ago

Beyond Air Provides LungFit® PH System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership with TrillaMed

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Sep 27, 2024, 7:32 AM EDT - 1 year ago

Beyond Air Announces Termination of the Loan and Security Agreements with Avenue Capital

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Sep 27, 2024, 7:30 AM EDT - 1 year ago

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 23, 2024, 8:00 AM EDT - 1 year ago

Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Beyond Air Registration statement: Registration Filing

Aug 20, 2024, 8:00 AM EDT - 1 year ago

Beyond Air Registration statement: Registration Filing

Beyond Air Quarterly report: Q1 2025

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Beyond Air Quarterly report: Q1 2025

Beyond Air Earnings release: Q1 2025

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Beyond Air Earnings release: Q1 2025

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Jul 31, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Jul 23, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Jul 16, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024

Beyond Air Earnings Call Transcript: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings Call Transcript: Q4 2024

Beyond Air Earnings release: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Earnings release: Q4 2024

Beyond Air Annual report: Q4 2024

Jun 24, 2024, 4:30 PM EDT - 2 years ago

Beyond Air Annual report: Q4 2024

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Jun 24, 2024, 4:15 PM EDT - 2 years ago

Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Beyond Air® Appoints David Webster as Chief Commercial Officer

Jun 13, 2024, 4:05 PM EDT - 2 years ago

Beyond Air® Appoints David Webster as Chief Commercial Officer

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

May 23, 2024, 4:09 PM EDT - 2 years ago

Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Mar 20, 2024, 9:00 AM EDT - 2 years ago

Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants

Say_Whaaaat
Say_Whaaaat Jun. 5 at 9:49 PM
$XAIR if they do a 10 to 1 split, that means pre both splits, for every 1000 shares you had you'll now how 5! Thanks Lisi!
0 · Reply
Fufat
Fufat Jun. 1 at 1:27 PM
$XAIR from $4.20 ish high to .45. This is criminal! Why thr steep drop? This has been shorted to high heaven. The company is still moving forward with their products. Nothing really changed other than the old CEO left. We shouldnt be down here but here we are!
1 · Reply
DingleberryDandy
DingleberryDandy Jun. 1 at 12:33 PM
$XAIR not dead yet. they can remain listed for a while longer. looks like a r/s is coming within a month
0 · Reply
DirtDobber
DirtDobber Jun. 1 at 12:10 PM
$XAIR let’s hope we get some saving action,
0 · Reply
Say_Whaaaat
Say_Whaaaat Jun. 1 at 12:05 PM
$XAIR the news this morning is "Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing"..... Yet the price goes red 😆. Good news bad.
1 · Reply
domarffm
domarffm Jun. 1 at 12:04 PM
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing $XAIR https://www.beyondair.net/news-events/press-releases?i=166822
0 · Reply
ncaro3
ncaro3 May. 26 at 12:07 PM
$XAIR Anybody want to chip in and buy this train wreck of a company? I found 57 cents in my couch cushions?
1 · Reply
iNVidiousGeek
iNVidiousGeek May. 23 at 4:58 PM
$XAIR Ready to catch it's Second breath! !
0 · Reply
uptrend2025
uptrend2025 May. 22 at 2:37 PM
$XAIR This one is super risk reward. It could go to cents or go to over $1 depending on Nasdaq ruling anyday now. I prefer to stay out and watch until decision is made.
1 · Reply
VernCapital
VernCapital May. 20 at 8:35 PM
$XAIR looking good - down to about 2cents now
1 · Reply
moon320
moon320 May. 19 at 1:19 PM
$XAIR I keep this in my portfolio as a reminder I am a lucky investor, not a good one. I bought this and just watched it whither. Great concept for solving a very real issue, but terrible execution.
2 · Reply
iNVidiousGeek
iNVidiousGeek May. 16 at 9:20 PM
$XAIR A split is coming after the middle of June. Near-term price,🥸 who knows?
1 · Reply
uptrend2025
uptrend2025 May. 14 at 9:42 PM
$XAIR I am not in but watching pending delisting decision.
0 · Reply
DingleberryDandy
DingleberryDandy May. 14 at 7:06 PM
$XAIR nasdaq listing decision happening today. This may finally be the end of the road
1 · Reply
PatentGrants
PatentGrants May. 13 at 7:56 PM
$XAIR Beyond Air has received a Notice of Allowance for a US patent titled "METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH". https://patentcenter.uspto.gov/applications/17779709/ifw/docs
1 · Reply
Say_Whaaaat
Say_Whaaaat May. 13 at 2:08 PM
$XAIR they diluted by adding about 2.5 million shares to the float in the recent past...
0 · Reply
SuperGreenToday
SuperGreenToday May. 13 at 12:46 AM
$XAIR
0 · Reply
Say_Whaaaat
Say_Whaaaat May. 12 at 1:14 PM
$XAIR I'm surprised there hasn't even been a weak buyout here. I thought the cancer trial was a big deal only to find out that they only did a half ass study that doesn't really hold water. Then the first version of the machine just sucked and really screwed us over. There hasn't been a buyout because there's not much here.... We were sold a pipe dream. Lol but not lol. Oh well... Expensive lesson learned..
0 · Reply
VernCapital
VernCapital May. 10 at 1:00 PM
$XAIR yes i really should know more about this company 😂😂😂😂
2 · Reply
iNVidiousGeek
iNVidiousGeek May. 8 at 10:26 PM
$XAIR Which way is the wind going to blow on this fine product? Signed an agreement with 2,000 hospitals. I believe the wind blows North!
0 · Reply
iNVidiousGeek
iNVidiousGeek May. 7 at 8:28 AM
$XAIR I XAIR you to One Doll Hair!
0 · Reply
iNVidiousGeek
iNVidiousGeek May. 6 at 10:19 PM
$XAIR Great product, lousy support from management. Maybe they get their act together and higher a PR firm. I believe if they would of made that investment already. We would be sitting at $5.00
1 · Reply